Nrx pharmaceuticals to report third quarter 2022 results on november 14, 2022

--company to host conference call november 14, 2022, at 8:00am et--- radnor, pa. , nov. 10, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage, biopharmaceutical company today announced that management will report third quarter 2022 financial results prior to the market open on november 14, 2022.
NRXP Ratings Summary
NRXP Quant Ranking